{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
InspireMD, Inc.
Is InspireMD, Inc. technically bullish or bearish?
As of June 5, 2025, the technical trend is bearish with moderate strength, driven by bearish weekly MACD and KST indicators, along with a bearish monthly RSI, despite a mildly bullish monthly MACD signal.
Who are in the management team of InspireMD, Inc.?
As of March 2022, the management team of InspireMD, Inc. includes Chairman Paul Stuka, CEO Marvin Slosman, Independent Vice Chairman Isaac Blech, and Directors Thomas Kester, Gary Roubin, Michael Berman, and Campbell Rogers. They are responsible for the company's strategic direction and operations.
What does InspireMD, Inc. do?
InspireMD, Inc. is a medical device company specializing in the MicroNet stent platform for vascular and coronary disease treatment. As of March 2025, it reported net sales of $2 million and a net loss of $11 million, with a market cap of $73.83 million.
How big is InspireMD, Inc.?
As of Jun 18, InspireMD, Inc. has a market capitalization of 73.83 million and reported net sales of 7.03 million with a net profit of -36.14 million over the latest four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
